
Pharmacoeconomic evaluation of nivolumab combined with gemcitabine and cisplatin chemotherapy regimen compared to gemcitabine and cisplatin regimen alone for the first-line treatment of advanced urothelial carcinoma
MOU Hong-li, LI Si-chen, FU Li-nan, WANG Shu-ling
Pharmacoeconomic evaluation of nivolumab combined with gemcitabine and cisplatin chemotherapy regimen compared to gemcitabine and cisplatin regimen alone for the first-line treatment of advanced urothelial carcinoma
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |